Detailed TOC of Global Cell and Gene Therapy Industry Trends Analysis Report 2026, Forecast to 2035 (Broken Down by Type, End User, Regional Analysis, and Competitive Landscape)
Table of Content
1 Market Overview
1.1 Product Definition and Market Characteristics
1.2 Global Cell and Gene Therapy Market Size
1.3 Market Segmentation
1.4 Regulatory Environment
2 Industry Chain Analysis
2.1 Industry Chain Analysis
2.2 Cell and Gene Therapy Raw Materials Analysis
2.2.1 Key Raw Materials Introduction
2.2.2 Key Suppliers of Raw Materials
2.3 Cell and Gene Therapy Business Mode and Production Process
2.3.1 Cell and Gene Therapy Business Mode Analysis
2.3.2 Production Process Analysis
2.4 Cell and Gene Therapy Cost Structure Analysis
2.4.1 Manufacturing Cost Structure of Cell and Gene Therapy
2.4.2 Raw Material Cost of Cell and Gene Therapy
2.4.3 Labor Cost of Cell and Gene Therapy
2.5 Market Channel Analysis
2.6 Major Downstream Customers Analysis
2.7 Alternative Product Analysis
3 Market Dynamics
3.1 Market Drivers
3.2 Market Constraints and Challenges
3.3 Emerging Market Trends
3.4 PESTEL Analysis
3.5 Consumer Insights Analysis
3.6 Impact of Russia and Ukraine War
4 Market Competitive Landscape
4.1 Global Cell and Gene Therapy Revenue and Market Share by Manufacturer (2020-2026)
4.2 Global Cell and Gene Therapy Sales Volume and Market Share by Manufacturer (2020-2026)
4.3 Global Cell and Gene Therapy Price by Manufacturer (2020-2026)
4.4 Cell and Gene Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
4.5 Global Key Manufacturers of Cell and Gene Therapy, Manufacturing Base Distribution and Headquarters
4.6 Global Key Manufacturers of Cell and Gene Therapy, Product Offered and Application
4.7 Cell and Gene Therapy Market Competitive Situation and Trends
4.7.1 Cell and Gene Therapy Market Concentration Rate
4.7.2 Global Top 3 and Top 6 Cell and Gene Therapy Players Market Share by Revenue
4.8 Industry News
4.8.1 Key Product Launch News
4.8.2 Mergers & Acquisitions, Expansion Plans
5 Global Cell and Gene Therapy Market Historical Development by Geographic Region (2020-2026)
5.1 Global Cell and Gene Therapy Market Historical Sales Volume by Geographic Region (2020-2026)
5.2 Global Cell and Gene Therapy Market Historical Revenue by Geographic Region (2020-2026)
5.3 North America Cell and Gene Therapy Market Status by Country (2020-2026)
5.3.1 North America Cell and Gene Therapy Sales Volume by Country (2020-2026)
5.3.2 North America Cell and Gene Therapy Revenue by Country (2020-2026)
5.3.3 United States Cell and Gene Therapy Sales Volume, Revenue and Growth (2020-2026)
5.3.4 Canada Cell and Gene Therapy Sales Volume, Revenue and Growth (2020-2026)
5.4 Europe Cell and Gene Therapy Market Status by Country (2020-2026)
5.4.1 Europe Cell and Gene Therapy Sales Volume by Country (2020-2026)
5.4.2 Europe Cell and Gene Therapy Revenue by Country (2020-2026)
5.4.3 Germany Cell and Gene Therapy Sales Volume, Revenue and Growth (2020-2026)
5.4.4 France Cell and Gene Therapy Sales Volume, Revenue and Growth (2020-2026)
5.4.5 United Kingdom Cell and Gene Therapy Sales Volume, Revenue and Growth (2020-2026)
5.4.6 Spain Cell and Gene Therapy Sales Volume, Revenue and Growth (2020-2026)
5.4.7 Russia Cell and Gene Therapy Sales Volume, Revenue and Growth (2020-2026)
5.4.8 Poland Cell and Gene Therapy Sales Volume, Revenue and Growth (2020-2026)
5.5 Asia Pacific Cell and Gene Therapy Market Status by Country (2020-2026)
5.5.1 Asia Pacific Cell and Gene Therapy Sales Volume by Country (2020-2026)
5.5.2 Asia Pacific Cell and Gene Therapy Revenue by Country (2020-2026)
5.5.3 China Cell and Gene Therapy Sales Volume, Revenue and Growth (2020-2026)
5.5.4 Japan Cell and Gene Therapy Sales Volume, Revenue and Growth (2020-2026)
5.5.5 South Korea Cell and Gene Therapy Sales Volume, Revenue and Growth (2020-2026)
5.5.6 Southeast Asia Cell and Gene Therapy Sales Volume, Revenue and Growth (2020-2026)
5.5.7 India Cell and Gene Therapy Sales Volume, Revenue and Growth (2020-2026)
5.5.8 Australia Cell and Gene Therapy Sales Volume, Revenue and Growth (2020-2026)
5.6 Latin America Cell and Gene Therapy Market Status by Country (2020-2026)
5.6.1 Latin America Cell and Gene Therapy Sales Volume by Country (2020-2026)
5.6.2 Latin America Cell and Gene Therapy Revenue by Country (2020-2026)
5.6.3 Mexico Cell and Gene Therapy Sales Volume, Revenue and Growth (2020-2026)
5.6.4 Brazil Cell and Gene Therapy Sales Volume, Revenue and Growth (2020-2026)
5.7 Middle East and Africa Cell and Gene Therapy Market Status by Country (2020-2026)
5.7.1 Middle East and Africa Cell and Gene Therapy Sales Volume by Country (2020-2026)
5.7.2 Middle East and Africa Cell and Gene Therapy Revenue by Country (2020-2026)
5.7.3 GCC Cell and Gene Therapy Sales Volume, Revenue and Growth (2020-2026)
5.7.4 South Africa Cell and Gene Therapy Sales Volume, Revenue and Growth (2020-2026)
6 Global Cell and Gene Therapy Market Historical Development by Product Type (2020-2026)
6.1 Cell and Gene Therapy Definition by Type
6.2 Global Cell and Gene Therapy Historical Sales Volume by Product Type (2020-2026)
6.3 Global Cell and Gene Therapy Historical Revenue by Product Type (2020-2026)
6.4 Global Cell and Gene Therapy Historical Price by Product Type (2020-2026)
6.5 Global Historical Sales Volume, Revenue and Growth Rate by Product Type (2020-2026)
6.5.1 Global Cell and Gene Therapy Historical Sales Volume, Revenue and Growth Rate of Rare Diseases (2020-2026)
6.5.2 Global Cell and Gene Therapy Historical Sales Volume, Revenue and Growth Rate of Oncology (2020-2026)
6.5.3 Global Cell and Gene Therapy Historical Sales Volume, Revenue and Growth Rate of Hematology (2020-2026)
6.5.4 Global Cell and Gene Therapy Historical Sales Volume, Revenue and Growth Rate of Cardiovascular (2020-2026)
6.5.5 Global Cell and Gene Therapy Historical Sales Volume, Revenue and Growth Rate of Ophthalmology (2020-2026)
6.5.6 Global Cell and Gene Therapy Historical Sales Volume, Revenue and Growth Rate of Neurology (2020-2026)
6.5.7 Global Cell and Gene Therapy Historical Sales Volume, Revenue and Growth Rate of Other Therapeutic Classes (2020-2026)
7 Global Cell and Gene Therapy Market Historical Development by End User (2020-2026)
7.1 Downstream Market Overview
7.2 Global Cell and Gene Therapy Historical Sales Volume by End User (2020-2026)
7.3 Global Cell and Gene Therapy Historical Revenue by End User (2020-2026)
7.4 Global Cell and Gene Therapy Historical Price by End User (2020-2026)
7.5 Global Historical Sales Volume, Revenue and Growth Rate by End User (2020-2026)
7.5.1 Global Cell and Gene Therapy Historical Sales Volume, Revenue and Growth Rate of Pharmaceutical and Biotechnology Companies (2020-2026)
7.5.2 Global Cell and Gene Therapy Historical Sales Volume, Revenue and Growth Rate of Research and Academic Institutions (2020-2026)
7.5.3 Global Cell and Gene Therapy Historical Sales Volume, Revenue and Growth Rate of Contract Research Organizations (CROs) (2020-2026)
7.5.4 Global Cell and Gene Therapy Historical Sales Volume, Revenue and Growth Rate of Hospital (2020-2026)
7.5.5 Global Cell and Gene Therapy Historical Sales Volume, Revenue and Growth Rate of Others (2020-2026)
8 Leading Companies Profiles
8.1 Novartis AG
8.1.1 Novartis AG Corporation Information
8.1.2 Novartis AG - Cell and Gene Therapy Product Portfolio and Specification
8.1.3 Novartis AG Performance Analysis (2020-2026)
8.1.4 Novartis AG Business and Markets Served
8.1.5 Novartis AG Recent Developments
8.2 Sibiono GeneTech Co. Ltd.,
8.2.1 Sibiono GeneTech Co. Ltd., Corporation Information
8.2.2 Sibiono GeneTech Co. Ltd., - Cell and Gene Therapy Product Portfolio and Specification
8.2.3 Sibiono GeneTech Co. Ltd., Performance Analysis (2020-2026)
8.2.4 Sibiono GeneTech Co. Ltd., Business and Markets Served
8.2.5 Sibiono GeneTech Co. Ltd., Recent Developments
8.3 Kite Pharma, Inc.
8.3.1 Kite Pharma, Inc. Corporation Information
8.3.2 Kite Pharma, Inc. - Cell and Gene Therapy Product Portfolio and Specification
8.3.3 Kite Pharma, Inc. Performance Analysis (2020-2026)
8.3.4 Kite Pharma, Inc. Business and Markets Served
8.3.5 Kite Pharma, Inc. Recent Developments
8.4 Pfizer, Inc.
8.4.1 Pfizer, Inc. Corporation Information
8.4.2 Pfizer, Inc. - Cell and Gene Therapy Product Portfolio and Specification
8.4.3 Pfizer, Inc. Performance Analysis (2020-2026)
8.4.4 Pfizer, Inc. Business and Markets Served
8.4.5 Pfizer, Inc. Recent Developments
8.5 Spark Therapeutics, Inc.
8.5.1 Spark Therapeutics, Inc. Corporation Information
8.5.2 Spark Therapeutics, Inc. - Cell and Gene Therapy Product Portfolio and Specification
8.5.3 Spark Therapeutics, Inc. Performance Analysis (2020-2026)
8.5.4 Spark Therapeutics, Inc. Business and Markets Served
8.5.5 Spark Therapeutics, Inc. Recent Developments
8.6 Organogenesis Holdings Inc.
8.6.1 Organogenesis Holdings Inc. Corporation Information
8.6.2 Organogenesis Holdings Inc. - Cell and Gene Therapy Product Portfolio and Specification
8.6.3 Organogenesis Holdings Inc. Performance Analysis (2020-2026)
8.6.4 Organogenesis Holdings Inc. Business and Markets Served
8.6.5 Organogenesis Holdings Inc. Recent Developments
8.7 Kolon TissueGene, Inc.
8.7.1 Kolon TissueGene, Inc. Corporation Information
8.7.2 Kolon TissueGene, Inc. - Cell and Gene Therapy Product Portfolio and Specification
8.7.3 Kolon TissueGene, Inc. Performance Analysis (2020-2026)
8.7.4 Kolon TissueGene, Inc. Business and Markets Served
8.7.5 Kolon TissueGene, Inc. Recent Developments
8.8 RENOVA THERAPEUTICS
8.8.1 RENOVA THERAPEUTICS Corporation Information
8.8.2 RENOVA THERAPEUTICS - Cell and Gene Therapy Product Portfolio and Specification
8.8.3 RENOVA THERAPEUTICS Performance Analysis (2020-2026)
8.8.4 RENOVA THERAPEUTICS Business and Markets Served
8.8.5 RENOVA THERAPEUTICS Recent Developments
8.9 Orchard Therapeutics plc.
8.9.1 Orchard Therapeutics plc. Corporation Information
8.9.2 Orchard Therapeutics plc. - Cell and Gene Therapy Product Portfolio and Specification
8.9.3 Orchard Therapeutics plc. Performance Analysis (2020-2026)
8.9.4 Orchard Therapeutics plc. Business and Markets Served
8.9.5 Orchard Therapeutics plc. Recent Developments
8.10 Amgen Inc.
8.10.1 Amgen Inc. Corporation Information
8.10.2 Amgen Inc. - Cell and Gene Therapy Product Portfolio and Specification
8.10.3 Amgen Inc. Performance Analysis (2020-2026)
8.10.4 Amgen Inc. Business and Markets Served
8.10.5 Amgen Inc. Recent Developments
8.11 Shanghai Sunway Biotech Co Ltd,
8.11.1 Shanghai Sunway Biotech Co Ltd, Corporation Information
8.11.2 Shanghai Sunway Biotech Co Ltd, - Cell and Gene Therapy Product Portfolio and Specification
8.11.3 Shanghai Sunway Biotech Co Ltd, Performance Analysis (2020-2026)
8.11.4 Shanghai Sunway Biotech Co Ltd, Business and Markets Served
8.11.5 Shanghai Sunway Biotech Co Ltd, Recent Developments
8.12 bluebird bio, Inc.
8.12.1 bluebird bio, Inc. Corporation Information
8.12.2 bluebird bio, Inc. - Cell and Gene Therapy Product Portfolio and Specification
8.12.3 bluebird bio, Inc. Performance Analysis (2020-2026)
8.12.4 bluebird bio, Inc. Business and Markets Served
8.12.5 bluebird bio, Inc. Recent Developments
8.13 Dendreon Pharmaceuticals LLC.
8.13.1 Dendreon Pharmaceuticals LLC. Corporation Information
8.13.2 Dendreon Pharmaceuticals LLC. - Cell and Gene Therapy Product Portfolio and Specification
8.13.3 Dendreon Pharmaceuticals LLC. Performance Analysis (2020-2026)
8.13.4 Dendreon Pharmaceuticals LLC. Business and Markets Served
8.13.5 Dendreon Pharmaceuticals LLC. Recent Developments
8.14 Vericel Corporation
8.14.1 Vericel Corporation Corporation Information
8.14.2 Vericel Corporation - Cell and Gene Therapy Product Portfolio and Specification
8.14.3 Vericel Corporation Performance Analysis (2020-2026)
8.14.4 Vericel Corporation Business and Markets Served
8.14.5 Vericel Corporation Recent Developments
8.15 ViroMed Co Ltd
8.15.1 ViroMed Co Ltd Corporation Information
8.15.2 ViroMed Co Ltd - Cell and Gene Therapy Product Portfolio and Specification
8.15.3 ViroMed Co Ltd Performance Analysis (2020-2026)
8.15.4 ViroMed Co Ltd Business and Markets Served
8.15.5 ViroMed Co Ltd Recent Developments
8.16 Human Stem Cells Institute
8.16.1 Human Stem Cells Institute Corporation Information
8.16.2 Human Stem Cells Institute - Cell and Gene Therapy Product Portfolio and Specification
8.16.3 Human Stem Cells Institute Performance Analysis (2020-2026)
8.16.4 Human Stem Cells Institute Business and Markets Served
8.16.5 Human Stem Cells Institute Recent Developments
8.17 Fibrocell Science, Inc.
8.17.1 Fibrocell Science, Inc. Corporation Information
8.17.2 Fibrocell Science, Inc. - Cell and Gene Therapy Product Portfolio and Specification
8.17.3 Fibrocell Science, Inc. Performance Analysis (2020-2026)
8.17.4 Fibrocell Science, Inc. Business and Markets Served
8.17.5 Fibrocell Science, Inc. Recent Developments
9 Global Cell and Gene Therapy Market Forecast by Product Type and End User (2026-2035)
9.1 Global Cell and Gene Therapy Market Forecast by Product Type (2026-2035)
9.1.1 Global Cell and Gene Therapy Sales Volume, Revenue Forecast and Growth Rate of Rare Diseases (2026-2035)
9.1.2 Global Cell and Gene Therapy Sales Volume, Revenue Forecast and Growth Rate of Oncology (2026-2035)
9.1.3 Global Cell and Gene Therapy Sales Volume, Revenue Forecast and Growth Rate of Hematology (2026-2035)
9.1.4 Global Cell and Gene Therapy Sales Volume, Revenue Forecast and Growth Rate of Cardiovascular (2026-2035)
9.1.5 Global Cell and Gene Therapy Sales Volume, Revenue Forecast and Growth Rate of Ophthalmology (2026-2035)
9.1.6 Global Cell and Gene Therapy Sales Volume, Revenue Forecast and Growth Rate of Neurology (2026-2035)
9.1.7 Global Cell and Gene Therapy Sales Volume, Revenue Forecast and Growth Rate of Other Therapeutic Classes (2026-2035)
9.2 Global Cell and Gene Therapy Market Forecast by End User (2026-2035)
9.2.1 Global Cell and Gene Therapy Sales Volume, Revenue Forecast and Growth Rate of Pharmaceutical and Biotechnology Companies (2026-2035)
9.2.2 Global Cell and Gene Therapy Sales Volume, Revenue Forecast and Growth Rate of Research and Academic Institutions (2026-2035)
9.2.3 Global Cell and Gene Therapy Sales Volume, Revenue Forecast and Growth Rate of Contract Research Organizations (CROs) (2026-2035)
9.2.4 Global Cell and Gene Therapy Sales Volume, Revenue Forecast and Growth Rate of Hospital (2026-2035)
9.2.5 Global Cell and Gene Therapy Sales Volume, Revenue Forecast and Growth Rate of Others (2026-2035)
10 Global Cell and Gene Therapy Market Forecast by Geographic Region (2026-2035)
10.1 Global Cell and Gene Therapy Sales Volume and Revenue Forecast by Geographic Region (2026-2035)
10.2 North America Cell and Gene Therapy Sales Volume, Revenue Forecast and Growth (2026-2035)
10.2.1 United States Cell and Gene Therapy Sales Volume, Revenue Forecast and Growth (2026-2035)
10.2.2 Canada Cell and Gene Therapy Sales Volume, Revenue Forecast and Growth (2026-2035)
10.3 Europe Cell and Gene Therapy Sales Volume, Revenue Forecast and Growth (2026-2035)
10.3.1 Germany Cell and Gene Therapy Sales Volume, Revenue Forecast and Growth (2026-2035)
10.3.2 France Cell and Gene Therapy Sales Volume, Revenue Forecast and Growth (2026-2035)
10.3.3 United Kingdom Cell and Gene Therapy Sales Volume, Revenue Forecast and Growth (2026-2035)
10.3.4 Spain Cell and Gene Therapy Sales Volume, Revenue Forecast and Growth (2026-2035)
10.3.5 Russia Cell and Gene Therapy Sales Volume, Revenue Forecast and Growth (2026-2035)
10.3.6 Poland Cell and Gene Therapy Sales Volume, Revenue Forecast and Growth (2026-2035)
10.4 Asia Pacific Cell and Gene Therapy Sales Volume, Revenue Forecast and Growth (2026-2035)
10.4.1 China Cell and Gene Therapy Sales Volume, Revenue Forecast and Growth (2026-2035)
10.4.2 Japan Cell and Gene Therapy Sales Volume, Revenue Forecast and Growth (2026-2035)
10.4.3 South Korea Cell and Gene Therapy Sales Volume, Revenue Forecast and Growth (2026-2035)
10.4.4 Southeast Asia Cell and Gene Therapy Sales Volume, Revenue Forecast and Growth (2026-2035)
10.4.5 India Cell and Gene Therapy Sales Volume, Revenue Forecast and Growth (2026-2035)
10.4.6 Australia Cell and Gene Therapy Sales Volume, Revenue Forecast and Growth (2026-2035)
10.5 Latin America Cell and Gene Therapy Sales Volume, Revenue Forecast and Growth (2026-2035)
10.5.1 Mexico Cell and Gene Therapy Sales Volume, Revenue Forecast and Growth (2026-2035)
10.5.2 Brazil Cell and Gene Therapy Sales Volume, Revenue Forecast and Growth (2026-2035)
10.6 Middle East and Africa Cell and Gene Therapy Sales Volume, Revenue Forecast and Growth (2026-2035)
10.6.1 GCC Cell and Gene Therapy Sales Volume, Revenue Forecast and Growth (2026-2035)
10.6.2 South Africa Cell and Gene Therapy Sales Volume, Revenue Forecast and Growth (2026-2035)
11 Appendix
11.1 Methodology
11.2 Research Data Source
11.2.1 Secondary Data
11.2.2 Primary Data
11.2.3 Market Size Estimation
11.2.4 Legal Disclaimer
Download FREE Sample Report
